Marinomed Biotech AG (MARI.VI)
EUR 12.45
(2.05%)
EUR 12.45
(2.05%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -4.48 EUR | -4.92% |
| 2022 | -4.27 EUR | -7.02% |
| 2021 | -3.99 EUR | 2.44% |
| 2020 | -4.09 EUR | 19.65% |
| 2019 | -5.09 EUR | 57.93% |
| 2018 | -12.10 EUR | -690.85% |
| 2017 | -1.53 EUR | -20.47% |
| 2016 | -1.27 EUR | -39.56% |
| 2015 | -0.91 EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -1.39 EUR | -78.21% |
| 2023 FY | - EUR | -4.92% |
| 2023 Q1 | -1.37 EUR | -242.5% |
| 2023 Q2 | -0.96 EUR | 29.93% |
| 2023 Q3 | -1.38 EUR | -43.75% |
| 2023 Q4 | -0.78 EUR | 43.48% |
| 2022 Q1 | -1.23 EUR | -539.29% |
| 2022 FY | - EUR | -7.02% |
| 2022 Q4 | -0.40 EUR | 68.99% |
| 2022 Q3 | -1.29 EUR | 3.01% |
| 2022 Q2 | -1.33 EUR | -8.13% |
| 2021 Q1 | -1.42 EUR | -71.08% |
| 2021 Q3 | -1.30 EUR | 16.13% |
| 2021 Q4 | 0.28 EUR | 121.54% |
| 2021 FY | - EUR | 2.44% |
| 2021 Q2 | -1.55 EUR | -9.15% |
| 2020 Q1 | -1.07 EUR | -48.61% |
| 2020 Q3 | -1.06 EUR | 5.36% |
| 2020 Q4 | -0.83 EUR | 21.7% |
| 2020 FY | - EUR | 19.65% |
| 2020 Q2 | -1.12 EUR | -4.67% |
| 2019 Q2 | -1.13 EUR | 48.64% |
| 2019 Q1 | -2.20 EUR | 58.8% |
| 2019 Q4 | -0.72 EUR | 15.29% |
| 2019 FY | - EUR | 57.93% |
| 2019 Q3 | -0.85 EUR | 24.78% |
| 2018 Q1 | -0.79 EUR | -558.33% |
| 2018 FY | - EUR | -690.85% |
| 2018 Q4 | -5.34 EUR | -372.57% |
| 2018 Q3 | -1.13 EUR | -109.26% |
| 2018 Q2 | -0.54 EUR | 31.65% |
| 2017 Q4 | -0.12 EUR | 0.0% |
| 2017 FY | - EUR | -20.47% |
| 2016 FY | - EUR | -39.56% |
| 2015 FY | - EUR | 0.0% |
| Name | Eps | Eps Difference |
|---|